Reber Genetics, we innovate and bridge Human Biotech and Animal Health
Reber Genetics co., Ltd., the world’s first and only GMP approved Porcine Reproductive and Respiratory Syndrome (PRRS) subunit vaccine provider, uses its unique protein-based Dendritic Cell (DC)-targeting subunit vaccine system together with reverse vaccinology (RV) analysis. Reber’s PRRS subunit vaccine can induce virus-specific INF-gamma cellular immunity and complement antibody against type1, type 2 and SEA PRRSV in pigs. In addition to PRRSV, our vaccine platform is also applied in the development of PCV2 vaccine, Mycoplasma vaccine, PRRS+PCV2 vaccine (ready-to-use), and African Swine Fever (ASF) vaccine. Furthermore, we also have collaborations to develop efficient Porcine epidemic diarrhea (PED) inactivated vaccine and canine cancer vaccine with National Taiwan University (NTU). Reber Genetics is looking for any possible forms of collaboration, such as product distributorship, ODM/OEM, and/or technology transfer. We provide professional and advanced immuno-solutions to our partners and customers in animal disease control and animal health industry.